IM Cannabis reported Q3 2024 revenue of $10.2M, missed analyst consensus of $14.5M by $4.3M. Diluted EPS came in at $-0.30, beat the $-0.70 consensus by $0.40.
Filings will appear here once submitted to SEC EDGAR.
Common questions about IM Cannabis's Q3 2024 earnings report.
IM Cannabis (IMCC) reported Q3 2024 earnings on November 14, 2024 before market open.
IM Cannabis reported revenue of $10.2M and diluted EPS of $-0.30 for Q3 2024.
Revenue missed the consensus estimate of $14.5M by $4.3M. EPS beat the consensus estimate of $-0.70 by $0.40.